What's in Sequential Medicine Ltd's pipeline?

Sequential Medicine Ltd has 3 drugs in our index: 2 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Sequential Medicine Ltd's portfolio?

Top competitors by shared drug class: Peking University People's Hospital, ASLAN Pharmaceuticals, Akeso, Addpharma Inc., Ahn-Gook Pharmaceuticals Co.,Ltd.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/sequential-medicine-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

Sequential Medicine Ltd — Portfolio Competitive Intelligence Brief

Sequential Medicine Ltd pipeline: 2 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
D+Z	D+Z	marketed	Direct-acting antiviral (DAA) combination	HCV NS5A protein and HCV NS5B RNA-dependent RNA polymerase	Virology / Hepatology
D+L	D+L	marketed			Nutritional/Wellness
SM-1	SM-1	phase 3	PD-1 inhibitor	PD-1	Oncology

Therapeutic area mix

Nutritional/Wellness · 1
Oncology · 1
Virology / Hepatology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Peking University People's Hospital · 2 shared drug classes
ASLAN Pharmaceuticals · 1 shared drug class
Akeso · 1 shared drug class
Addpharma Inc. · 1 shared drug class
Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class
Ain Shams University · 1 shared drug class
ATGC Co., Ltd. · 1 shared drug class
ANRS, Emerging Infectious Diseases · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Sequential Medicine Ltd:

Cite this brief

Drug Landscape (2026). Sequential Medicine Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/sequential-medicine-ltd. Accessed 2026-05-14.